EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
EIGR
Delisted
EIGR was delisted on the 10th of April, 2024.
91 hedge funds and large institutions have $275M invested in Eiger BioPharmaceuticals, Inc. in 2019 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 35 increasing their positions, 23 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
91
Holders Change
+7
Holders Change %
+8.33%
% of All Funds
1.8%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.12%
New
14
Increased
35
Reduced
23
Closed
7
Calls
$290K
Puts
$182K
Net Calls
+$108K
Net Calls Change
+$108K
Top Buyers
| 1 |
DC
Davenport & Co
Richmond,
Virginia
|
$3.79M |
| 2 |
BlackRock
New York
|
$28.2M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
$17.9M |
| 4 |
Two Sigma Investments
New York
|
$1.48M |
| 5 |
Two Sigma Advisers
New York
|
$1.07M |
Top Sellers
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
$6.7M |
| 2 |
BI
BVF Inc
San Francisco,
California
|
$2.14M |
| 3 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
$12.4M |
| 4 |
BC
Broadfin Capital
New York
|
$18.4M |
| 5 |
TI
Telemetry Investments
New York
|
$2.02M |
